Moreover, the use of ASO small nucleic acid drugs to modulate the splicing pattern of PKM pre-mRNA and facilitate the production of PKM1 instead of PKM2 in cancer cells can effectively impede cell proliferation and delay tumor formation. Here, PKM is linked to cancer.